Key Statistics for DRRD
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (INR) (ttm)
|Est. EPS (INR) (03/2014)
|Est. PEG Ratio
|Market Cap (M INR)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (INR)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for DRRD
- Net Income (M/INR)
Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world.
More Company Profile & Key Executives for DRRD
|G V PrasadChairman/CEO||Satish ReddyVice Chairman/Mng Dir/COO|
|Saumen ChakrabortyPresident/CFO/Global Head|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries